A rapid approach to lipid profiling of mycobacteria using 2D HSQC NMR maps

Journal of Lipid Research

Volumn 49, Issue 2, 2008, Pages 455-463

  Mahrous, Engy A ^a   Lee, Robin B ^a   Lee, Richard E ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Lipidomics; Phenolic glycolipids; Tuberculosis; Two dimensional 1H 13C heteronuclear single quantum coherence nuclear magnetic resonance

Indexed keywords

ETHAMBUTOL; MEMBRANE LIPID; VIRULENCE FACTOR;

ARTICLE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC VARIABILITY; HETERONUCLEAR SINGLE QUANTUM COHERENCE; LIPID ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ETHAMBUTOL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LIPIDS; MYCOBACTERIUM; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM ULCERANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; VIRULENCE FACTORS;

EID: 38949108997     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700440-JLR200     Document Type: Article

References (33)

1. McNeil, M. R., and P. J. Brennan. 1991. Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance: some thoughts and possibilities arising from recent structural information. Res. Microbiol. 142: 451-463.
2. Laneelle, G., and M. Daffe. 1991. Mycobacterial cell wall and pathogenicity: a lipodologist's view. Res. Microbiol. 142: 433-437.
3. Hunter, R. L., M. R. Olsen, C. Jagannath, and J. K. Actor. 2006. Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann. Clin. Lab. Sci. 36: 371-386.
4. Dubnau, E., J. Chan, C. Raynaud, V. P. Mohan, M. A. Laneelle, K. Yu, A. Quemard, I. Smith, and M. Daffe. 2000. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol. Microbiol. 36: 630-637.
5. Onwueme, K. C., C. J. Vos, J. Zurita, J. A. Ferreras, and L. E. Quadri. 2005. The dimycocerosate ester polyketide virulence factors of mycobacteria. Prog. Lipid Res. 44: 259-302.
6. Reed, M. B., P. Domenech, C. Manca, H. Su, A. K. Barczak, B. N. Kreiswirth, G. Kaplan, and C. E. Barry, 3rd. 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature. 431: 84-87.
7. De Voss, J. J., K. Rutter, B. G. Schroeder, H. Su, Y. Zhu, and C. E. Barry, 3rd. 2000. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc. Natl. Acad. Sci. USA. 97: 1252-1257.
8. Cox, J. S., B. Chen, M. McNeil, and W. R. Jacobs, Jr. 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature. 402: 79-83.
9. Pabst, M. J., J. M. Gross, J. P. Brozna, and M. B. Goren. 1988. Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J. Immunol. 140: 634-640.
10. Brennan, P. J. 2003. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb.). 83: 91-97.
11. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64: 29-63.
12. Dobson, G., D. E. Minnikin, S. M. Minnikin, M. Parlett, M. Goodfellow, M. Ridell, and M. Magnusson. 1985. Systematic analysis of complex mycobacterial lipids. In Chemical Methods in Bacterial Systematics. M. Goodfellow and D. E. Minnikin, editors. Academic Press, London. 237-265.
13. Jain, M., C. J. Petzold, M. W. Schelle, M. D. Leavell, J. D. Mougous, C. R. Bertozzi, J. A. Leary, and J. S. Cox. 2007. Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling. Proc. Natl. Acad. Sci. USA. 104: 5133-5138.
14. Shui, G., A. K. Bendt, K. Pethe, T. Dick, and M. R. Wenk. 2007. Sensitive profiling of chemically diverse bioactive lipids. J. Lipid Res. 48: 1976-1984.
15. Lee, R. E., W. Li, D. Chatterjee, and R. E. Lee. 2005. Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed. Glycobiology. 15: 139-151.
16. Li, W., R. E. Lee, R. E. Lee, and J. Li. 2005. Methods for acquisition and assignment of multidimensional high-resolution magic angle spinning NMR of whole cell bacteria. Anal. Chem. 77: 5785-5792.
17. Escuyer, V. E., M. A. Lety, J. B. Torrelles, K. H. Khoo, J. B. Tang, C. D. Rithner, C. Frehel, M. R. McNeil, P. J. Brennan, and D. Chatterjee. 2001. The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. J. Biol. Chem. 276: 48854-48862.
18. Khoo, K. H., E. Douglas, P. Azadi, J. M. Inamine, G. S. Besra, K. Mikusova, P. J. Brennan, and D. Chatterjee. 1996. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol. J. Biol. Chem. 271: 28682-28690.
19. Alderwick, L. J., M. Seidel, H. Sahm, G. S. Besra, and L. Eggeling. 2006. Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. J. Biol. Chem. 281: 15653-15661.
20. Kilburn, J. O., and K. Takayama. 1981. Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 20: 401-404.
21. George, K. M., D. Chatterjee, G. Gunawardana, D. Welty, J. Hayman, R. Lee, and P. L. Small. 1999. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science. 283: 854-857.
22. Mve-Obiang, A., R. E. Lee, E. S. Umstot, A. K. Trott, T. C. Grammer, J. M. Parker, B. S. Ranger, R. Grainger, E. A. Mahrous, and P. L. Small. 2005. A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin. Infect. Immun. 73: 3307-3312.
23. Ranger, B. S., E. A. Mahrous, L. Mosi, S. Adusumilli, R. E. Lee, A. Colorni, M. Rhodes, and P. L. Small. 2006. Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F. Infect. Immun. 74: 6037-6045.
24. Stinear, T. P., A. Mve-Obiang, P. L. Small, W. Frigui, M. J. Pryor, R. Brosch, G. A. Jenkin, P. D. Johnson, J. K. Davies, R. E. Lee, et al. 2004. Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc. Natl. Acad. Sci. USA. 101: 1345-1349.
25. Trott, K. A., B. A. Stacy, B. D. Lifland, H. E. Diggs, R.M. Harland, M. K. Khokha, T. C. Grammer, and J. M. Parker. 2004. Characterization of a Mycobacterium ulcerans-like infection in a colony of African tropical clawed frogs (Xenopus tropicalis). Comp. Med. 54: 309-317.
26. Stinear, T. P., T. Seemann, S. Pidot, W. Frigui, G. Reysset, T. Garnier, G. Meurice, D. Simon, C. Bouchier, L. Ma, et al. 2007. Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res. 17: 192-200.
27. Yip, M. J., J. L. Porter, J. A. Fyfe, C. J. Lavender, F. Portaels, M. Rhodes, H. Kator, A. Colorni, G. A. Jenkin, and T. Stinear. 2007. Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor. J. Bacteriol. 189: 2021-2029.
28. Daffe, M., A. Varnerot, and V. V. Levy-Frebault. 1992. The phenolic mycoside of Mycobacterium ulcerans: structure and taxonomic implications. J. Gen. Microbiol. 138: 131-137.
29. Riviere, M., J. J. Fournie, and G. Puzo. 1987. A novel mannose containing phenolic glycolipid from Mycobacterium kansasii. J. Biol. Chem. 262: 14879-14884.
30. Chatterjee, D., C. M. Bozic, C. Knisley, S. N. Cho, and P. J. Brennan. 1989. Phenolic glycolipids of Mycobacterium bovis: new structures and synthesis of a corresponding seroreactive neoglycoprotein. Infect. Immun. 57: 322-330.
31. Dobson, G., D. E. Minnikin, G. S. Besra, A. I. Mallet, and M. Magnusson. 1990. Characterisation of phenolic glycolipids from Mycobacterium marinum. Biochim. Biophys. Acta. 1042: 176-181.
32. Yamada Y, Inouye G, Tahara Y, and Kondo K. 1976. On the chemical structure of menaquinones with the tetrahydrogenated isoprenoid side chain. Biochim Biophys Acta. 486:195-203.
33. Gilleron M, Nigou J, Cahuzac B, Puzo G. 1999. Structural study of the lipomannans from Mycobacterium bovis BCG: characterisation of multiacylated forms of the phosphatidyl-myo-inositol anchor. J Mol Biol. 285:2147-2160.